Northern Trust Company of Connecticut’s Teva Pharmaceuticals TEVA Stock Holding History

Northern Trust Company of Connecticut’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$15.7M	Sell	391,156 -52,972	-12%	-$2.09M	0.1%	296
2013 Q3	$16.8M	Sell	444,128 -61,645	-12%	-$2.4M	0.11%	261
2013 Q2	$19.8M	Buy	+505,773	New	+$19.7M	0.13%	198

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Company of Connecticut's TEVA Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Teva Pharmaceuticals (TEVA) stake by 12% in Q4 2013, selling an estimated $2.09M and leaving 391,156 shares worth $15.7M. The position accounts for 0.1% of the portfolio, ranked #296.

Northern Trust Company of Connecticut first reported a position in TEVA in Q2 2013 and has held it in 3 quarters since. The position peaked at $19.8M in Q2 2013. 728 funds tracked by Wall St. Rank hold TEVA as of Q4 2013.

Northern Trust Company of Connecticut held 391,156 shares of Teva Pharmaceuticals worth $15.7M as of Q4 2013.
Northern Trust Company of Connecticut sold 52,972 Teva Pharmaceuticals shares in Q4 2013, an estimated $2.09M.
Teva Pharmaceuticals made up 0.1% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #296 holding.
Northern Trust Company of Connecticut first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
Northern Trust Company of Connecticut's Teva Pharmaceuticals position peaked at $19.8M in Q2 2013.
728 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.